| scholarly article | Q13442814 |
| P50 | author | Kathleen E. Malone | Q110376035 |
| Sandra A. Norman | Q114515980 | ||
| Robert Spirtas | Q114515981 | ||
| Giske Ursin | Q46387795 | ||
| Leslie Bernstein | Q60607806 | ||
| Polly A Marchbanks | Q96619661 | ||
| P2093 | author name string | Melissa Bondy | |
| Mitchell H Gail | |||
| Michael S Simon | |||
| Worta McCaskill-Stevens | |||
| Garnet L Anderson | |||
| Joseph P Costantino | |||
| David Pee | |||
| Lisa Newman | |||
| Mano Selvan | |||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 1782-1792 | |
| P577 | publication date | 2007-11-27 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Projecting individualized absolute invasive breast cancer risk in African American women | |
| P478 | volume | 99 |
| Q50597400 | A comparison between different prediction models for invasive breast cancer occurrence in the French E3N cohort. |
| Q37877651 | A review of body size and breast cancer risk in Hispanic and African American women |
| Q92199197 | A systematic review and quality assessment of individualised breast cancer risk prediction models |
| Q91994082 | A way forward for cancer prevention therapy: personalized risk assessment |
| Q41726822 | Addressing barriers to uptake of breast cancer chemoprevention for patients and providers |
| Q83917287 | American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction |
| Q35909006 | An exercise trial targeting African-American women with metabolic syndrome and at high risk for breast cancer: Rationale, design, and methods |
| Q111440867 | Artificial Intelligence and Early Detection of Pancreatic Cancer |
| Q47733514 | Assessing Breast Cancer Risk Estimates Based on the Gail Model and Its Predictors in Qatari Women |
| Q39002424 | Assessing absolute changes in breast cancer risk due to modifiable risk factors |
| Q39944741 | Assessing breast cancer risk and providing treatment recommendations: immediate impact of an educational session |
| Q34481239 | Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study). |
| Q35185159 | Assessing the goodness of fit of personal risk models |
| Q52657619 | Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis. |
| Q93059426 | Assessment of the Gail Model in Estimating the Risk of Breast Cancer: Effect of Cancer Worry and Risk in Healthy Women |
| Q94453600 | Assessment of the risk of developing breast cancer using the Gail model in Asian females: A systematic review |
| Q34039859 | Baseline mammographic breast density and the risk of invasive breast cancer in postmenopausal women participating in the NSABP study of tamoxifen and raloxifene (STAR). |
| Q34398521 | Belief in numbers: When and why women disbelieve tailored breast cancer risk statistics |
| Q35023437 | Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older |
| Q36456742 | Benign breast disease and the risk of subsequent breast cancer in African American women |
| Q35812120 | Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ |
| Q35866151 | Breast Cancer Risk Assessment Among Low-Income Women of Color in Primary Care: A Pilot Study |
| Q87909686 | Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening |
| Q93169632 | Breast cancer chemoprevention: An update on current practice and opportunities for primary care physicians |
| Q38599973 | Breast cancer prevention with anti-estrogens: review of the current evidence and future directions |
| Q33739374 | Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance |
| Q35682143 | Breast cancer risk assessment in 64,659 women at a single high-volume mammography clinic |
| Q37139866 | Breast cancer risk assessments comparing Gail and CARE models in African-American women |
| Q39263736 | Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications. |
| Q51114540 | Breast cancer risk prediction accuracy in Jewish Israeli high-risk women using the BOADICEA and IBIS risk models. |
| Q64074174 | Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model |
| Q42852622 | Breast density influences tumor subtypes and tumor aggressiveness |
| Q38727084 | Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ |
| Q35998680 | Chemoprevention for Breast Cancer |
| Q37707373 | Clinical application of breast cancer risk assessment models |
| Q37103070 | Colorectal cancer risk prediction tool for white men and women without known susceptibility |
| Q24641969 | Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer |
| Q37690575 | Common breast cancer risk variants in the post-COGS era: a comprehensive review |
| Q90250007 | Comparison of Questionnaire-Based Breast Cancer Prediction Models in the Nurses' Health Study |
| Q37693247 | Correlation of ductal lavage cytology with ductoscopy-directed duct excision histology in women at high risk for developing breast cancer: a prospective, single-institution trial |
| Q40220712 | Cross-sectional study to assess the association of population density with predicted breast cancer risk |
| Q33599463 | Current strategies for the prevention of breast cancer |
| Q38151510 | Development and validation of risk models and molecular diagnostics to permit personalized management of cancer |
| Q52573455 | Development of a Breast Cancer Risk Prediction Model for Women in Nigeria. |
| Q33885337 | Development of a Cancer Risk Prediction Tool for Use in the UK Primary Care and Community Settings |
| Q37699255 | Discovery and replication of microRNAs for breast cancer risk using genome-wide profiling |
| Q36547262 | Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status |
| Q64886022 | Do cancer risk and benefit-harm ratios influence women's consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries. |
| Q44942964 | Duration of an intervention's impact on perceived breast cancer risk |
| Q37081034 | Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan |
| Q33897605 | Effect of changing breast cancer incidence rates on the calibration of the Gail model |
| Q89429102 | Effect of exercise on metabolic syndrome in black women by family history and predicted risk of breast cancer: The FIERCE Study |
| Q57313402 | Equivalence of improvement in area under ROC curve and linear discriminant analysis coefficient under assumption of normality |
| Q64055568 | Establishing Cohorts to Generate the Evidence Base to Reduce the Burden of Breast Cancer in Sub-Saharan Africa: Results From a Feasibility Study in Kenya |
| Q34135724 | Estimating and disclosing the risk of developing Alzheimer‘s disease: challenges, controversies and future directions |
| Q88402288 | Examining Mammography Use by Breast Cancer Risk, Race, Nativity, and Socioeconomic Status |
| Q51701305 | Explicating perceived barriers to mammography for the USCREEN project: concerns about breast implants, faith violations, and perceived recommendations. |
| Q38739215 | Extensions of the Rosner-Colditz breast cancer prediction model to include older women and type-specific predicted risk. |
| Q36317511 | Facilitating informed decisions about breast cancer screening: development and evaluation of a web-based decision aid for women in their 40s |
| Q34185689 | Five-Year and Lifetime Risk of Breast Cancer among U.S. Subpopulations: Implications for Magnetic Resonance Imaging Screening |
| Q92877007 | Gail Model Underestimates Breast Cancer Risk in Thai Population |
| Q33794872 | Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile |
| Q33965090 | Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women |
| Q33767120 | How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention? |
| Q92355423 | Identifying Women at High Risk for Breast Cancer Using Data From the Electronic Health Record Compared With Self-Report |
| Q34253058 | Impact of correlation on predictive ability of biomarkers |
| Q37724736 | Incremental impact of breast cancer SNP panel on risk classification in a screening population of white and African American women |
| Q37304142 | Individual breast cancer risk assessment in underserved populations: integrating empirical bioethics and health disparities research |
| Q28389384 | JNCI and cancer prevention |
| Q96302976 | Key steps for effective breast cancer prevention |
| Q35034785 | Korean risk assessment model for breast cancer risk prediction |
| Q35895900 | Lifetime and 5 years risk of breast cancer and attributable risk factor according to Gail model in Iranian women |
| Q45953957 | MODEL FALLS SHORT WHEN PREDICTING BREAST CANCER RISK IN BLACK WOMEN. |
| Q26785571 | MRI screening for breast cancer in women at high risk; is the Australian breast MRI screening access program addressing the needs of women at high risk of breast cancer? |
| Q35786337 | Mammographic Breast Density and Common Genetic Variants in Breast Cancer Risk Prediction |
| Q33573827 | Mammographic breast density as a risk factor for breast cancer: awareness in a recently screened clinical sample |
| Q38415320 | Molecular epidemiology, and possible real-world applications in breast cancer |
| Q36117814 | My Lived Experiences Are More Important Than Your Probabilities: The Role of Individualized Risk Estimates for Decision Making about Participation in the Study of Tamoxifen and Raloxifene (STAR). |
| Q33763413 | National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial: advancing the science of recruitment and breast cancer risk assessment in minority communities |
| Q37529123 | Patterns of breast magnetic resonance imaging use in community practice |
| Q33571698 | Perceived versus objective breast cancer risk in diverse women |
| Q90300125 | Performance of breast cancer risk assessment models in a large mammography cohort |
| Q28083876 | Personalized assessment and management of women at risk for breast cancer in North America |
| Q34815108 | Personalized estimates of breast cancer risk in clinical practice and public health |
| Q28072526 | Physician and Patient Barriers to Breast Cancer Preventive Therapy |
| Q36009831 | Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk |
| Q46203756 | Pre-empting breast cancer: where do we go from here? |
| Q98613890 | Predictably unequal: understanding and addressing concerns that algorithmic clinical prediction may increase health disparities |
| Q31050730 | Predicting Barrett's Esophagus in Families: An Esophagus Translational Research Network (BETRNet) Model Fitting Clinical Data to a Familial Paradigm |
| Q33588556 | Predicting dementia: role of dementia risk indices |
| Q37274596 | Predicting risk of dementia in older adults: The late-life dementia risk index |
| Q35879319 | Predictors of Non-Adherence to Breast Cancer Screening among Hospitalized Women |
| Q30948683 | Predictors of preoperative MRI for breast cancer: differences by data source |
| Q35995305 | Preliminary evaluation of the publicly available Laboratory for Breast Radiodensity Assessment (LIBRA) software tool: comparison of fully automated area and volumetric density measures in a case-control study with digital mammography |
| Q37454802 | Prevalence of chemopreventive agent use among hospitalised women at high risk for breast cancer: a cross-sectional study |
| Q44958136 | Prevention of breast cancer (part I): epidemiology, risk factors, and risk assessment tools |
| Q28390064 | Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk |
| Q39076835 | Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women |
| Q30501421 | Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women |
| Q35168773 | Prospective approach to breast cancer risk prediction in African American women: the black women's health study model |
| Q64890542 | Public health application of predictive modeling: an example from farm vehicle crashes |
| Q42419549 | Randomized trial of a phone- and web-based weight loss program for women at elevated breast cancer risk: the HELP study |
| Q39485105 | Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial |
| Q47182386 | Response to breast health screening program at a not-for-profit clinic for working poor, uninsured, ethnically diverse women |
| Q57105145 | Review of non-clinical risk models to aid prevention of breast cancer |
| Q37176019 | Risk assessment model for invasive breast cancer in Hong Kong women. |
| Q35090578 | Risk factor modification and projections of absolute breast cancer risk |
| Q61797741 | Risk prediction for breast Cancer in Han Chinese women based on a cause-specific Hazard model |
| Q34916417 | Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies |
| Q37955078 | Risk prediction models of breast cancer: a systematic review of model performances |
| Q92734170 | Risk versus Benefit of Chemoprevention among Raloxifene and Tamoxifen Users with a Family History of Breast Cancer |
| Q34974865 | Risk-benefit profiles of women using tamoxifen for chemoprevention |
| Q36322904 | SNPs and breast cancer risk prediction for African American and Hispanic women |
| Q37097084 | Tamoxifen vs Raloxifene vs Exemestane for Chemoprevention |
| Q39424104 | Technology- and Phone-Based Weight Loss Intervention: Pilot RCT in Women at Elevated Breast Cancer Risk |
| Q90148058 | The Application of Gail Model to Predict the Risk of Developing Breast Cancer among Jordanian Women |
| Q61814544 | The Impact of a Risk-Based Breast Cancer Screening Decision Aid on Initiation of Mammography Among Younger Women: Report of a Randomized Trial |
| Q34276186 | The changes in female physical and childbearing characteristics in China and potential association with risk of breast cancer. |
| Q47348939 | Theorizing the Impact of Targeted Narratives: Model Admiration and Narrative Memorability |
| Q64240122 | Towards a more precise and individualized assessment of breast cancer risk |
| Q43435271 | Traditional dietary pattern of South America is linked to breast cancer: an ongoing case-control study in Argentina. |
| Q36294980 | Twenty-five years of breast cancer risk models and their applications |
| Q83424149 | Update in women's health |
| Q37025404 | Updating risk prediction tools: a case study in prostate cancer |
| Q37172219 | Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model |
| Q36953551 | Validation of a breast cancer risk prediction model developed for Black women |
| Q57040851 | Validation of a genetic risk score for Arkansas women of color |
| Q53692864 | Views of Low-Income Women of Color at Increased Risk for Breast Cancer. |
| Q46124505 | Web-based self-monitoring for weight loss among overweight/obese women at increased risk for breast cancer: the HELP pilot study |
| Q36081851 | Why are Tailored Messages More Effective? A Multiple Mediation Analysis of a Breast Cancer Screening Intervention |
| Q89547730 | iCARE: An R package to build, validate and apply absolute risk models |
Search more.